KMT2C and mantle cell lymphoma: Compared to those with a low Ki-67 level, AH-MCL patients with Ki-67 ≥ 50% have exclusive mutations in TP53, RANBP2, SMARCA4, KMT2C, SPEN, and NSD2 (WHSC1) [86, 88].